bostonbased valo 300m seriesmccoy, bostonbased valo health seriesmccoy wichita, bostonbased valo seriesmccoy wichita, bostonbased valo health 300m seriesmccoy wichita, valo health seriesmccoy businessjournal, bostonbased 300m seriesmccoy businessjournal, valo seriesmccoy wichita businessjournal, bostonbased 300m wichita businessjournal, valo health 300m wichita, bostonbased valo wichita businessjournal, series sageview capital 71mspencer businessjournal, bostonbased valo health 300m wichita.
Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B — A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.
